Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Age, Children, cleared, cutoff, cytarabine, dollar, dose, endpoint, escalation, explore, FLA, fludarabine, Group, healthy, iPSP, lieu, myeloablative, nearest, observed, open, payable, pediatric, Policy, rounded, Supplemental, topline, unrestricted, workforce
Removed:
applied, cancelable, extend, IBR, line, monitor, noncancelable, pandemic, penalty, reaching, top
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view